Roche Holding AG (RO)

Currency in CHF
407.40
-3.80(-0.92%)
Delayed Data·
RO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
406.00409.00
52 wk Range
270.80415.60
Key Statistics
Bid/Ask
407.60 / 408.00
Prev. Close
411.2
Open
407.2
Day's Range
406-409
52 wk Range
270.8-415.6
Volume
7.98K
Average Volume (3m)
28.23K
1-Year Change
49.8896%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
396.00
Downside
-2.80%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Roche Holding AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 396.00
(-2.80% Downside)

Earnings

Latest Release
Oct 22, 2026
EPS / Forecast
-- / --
Revenue / Forecast
16.13B / 15.74B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 15.50
Dividend Yield
2.63%
Industry Median 1.94%
Annualized payout
10.80
Paid annually
5-Years Growth
+1.49%
Growth Streak

RO Income Statement

Compare RO to Peers and Sector

Metrics to compare
RO
Peers
Sector
Relationship
P/E Ratio
0.0x21.3x−0.3x
PEG Ratio
0.000.110.00
Price/Book
0.0x2.6x2.6x
Price / LTM Sales
0.0x2.9x2.8x
Upside (Analyst Target)
−2.9%−4.7%66.4%
Fair Value Upside
Unlock9.5%9.0%Unlock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.

Employees
103249

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
230.37M28.91%94.73B
Other Institutional Investors
686.57K0.09%282.32M
Public Companies & Retail Investors
565.71M71.00%232.62B
Total
796.77M100.00%327.63B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
UBS Asset Management AG4.29%34,209,62514,066,998
BlackRock, Inc.4.28%34,121,89714,030,924

People Also Watch

131.98
NOVN
-1.35%
22.175
IBE
-0.02%
10.2620
SAN
+1.42%
1,413.60
ASML
+0.06%
84.42
TTEF
-1.18%

FAQ

What Is the Roche Holding (RO) Stock Price Today?

The Roche Holding stock price today is 407.40 CHF.

What Stock Exchange Does Roche Holding Trade On?

Roche Holding is listed and trades on the Switzerland Stock Exchange.

What Is the Stock Symbol for Roche Holding?

The stock symbol for Roche Holding is "RO."

Does Roche Holding Pay Dividends? What’s The Current Dividend Yield?

The Roche Holding dividend yield is 2.6%%.

What Is the Roche Holding Market Cap?

As of today, Roche Holding market cap is 324.60B CHF.

What Is Roche Holding's Earnings Per Share (TTM)?

The Roche Holding EPS (TTM) is 15.50.

When Is the Next Roche Holding Earnings Date?

Roche Holding will release its next earnings report on Jan 28, 2027.

From a Technical Analysis Perspective, Is RO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Roche Holding Stock Split?

Roche Holding has split 1 times.

How Many Employees Does Roche Holding Have?

Roche Holding has 103249 employees.

What is the current trading status of Roche Holding (RO)?

As of Nov 02, 2026, Roche Holding (RO) is trading at a price of 407.40 CHF, with a previous close of 411.20 CHF. The stock has fluctuated within a day range of 406.00 CHF to 409.00 CHF, while its 52-week range spans from 270.80 CHF to 415.60 CHF.

What Is Roche Holding (RO) Price Target According to Analysts?

The average 12-month price target for Roche Holding is 396.00 CHF, with a high estimate of 396 CHF and a low estimate of 396 CHF. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -2.80% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.